Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years

References

• BlauNvan SpronsenFJLevyHLPhenylketonuriaLancet201037697501417142720971365
   PubMed Web of Science ®Google Scholar
• van SpronsenFJvan WegbergAMAhringKKey European guidelines for the diagnosis and management of patients with phenylketonuriaLancet Diabetes Endocrinol20175974375628082082
   PubMed Web of Science ®Google Scholar
• DyerCAPathophysiology of phenylketonuriaMent Retard Dev Disabil Res Rev199952104112
   Google Scholar
• JahjaRvan SpronsenFJde SonnevilleLMJLong-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO StudyBehav Genet201747548649728776207
   PubMed Web of Science ®Google Scholar
• de GrootMJHoeksmaMBlauNReijngoudDJvan SpronsenFJPathogenesis of cognitive dysfunction in phenylketonuria: review of hypothesesMol Genet Metab201099Suppl 1S86S8920123477
   PubMed Web of Science ®Google Scholar
• JahjaRvan SpronsenFJde SonnevilleLMJSocial-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO studyJ Inherit Metab Dis201639335536226914933
   PubMed Web of Science ®Google Scholar
• MacleodMDMunroJFLedinghamJGFarquharJWManagement of the extrapyramidal manifestations of phenylketonuria with L-dopaArch Dis Child19835864574586859941
   PubMed Web of Science ®Google Scholar
• GrossPTBerlowSSchuettVEFarielloRGEEG in phenylketonuria. Attempt to establish clinical importance of EEG changesArch Neurol19813821221267469835
   PubMedGoogle Scholar
• AndersonPJLeuzziVWhite matter pathology in phenylketonuriaMol Genet Metab201099Suppl 1S3S920123467
   PubMed Web of Science ®Google Scholar
• CampKMParisiMAAcostaPBPhenylketonuria Scientific Review Conference: state of the science and future research needsMol Genet Metab201411228712224667081
   PubMed Web of Science ®Google Scholar
• PengHPeckDWhiteDAChristSETract-based evaluation of white matter damage in individuals with early-treated phenylketonuriaJ Inherit Metab Dis201437223724324043380
   PubMed Web of Science ®Google Scholar
• Antenor-DorseyJAHersheyTRutlinJWhite matter integrity and executive abilities in individuals with phenylketonuriaMol Genet Metab2013109212513123608077
   PubMed Web of Science ®Google Scholar
• ClearyMAWalterJHWraithJEMagnetic resonance imaging of the brain in phenylketonuriaLancet1994344891587907912392
   PubMed Web of Science ®Google Scholar
• HoodAAntenor-DorseyJARutlinJProlonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuriaMol Genet Metab20151141192425481106
   PubMed Web of Science ®Google Scholar
• LeuzziVTosettiMMontanaroDThe pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) studyJ Inherit Metab Dis200730220921617245558
   PubMed Web of Science ®Google Scholar
• PietzJKreisRSchmidtHPhenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatmentRadiology199620124134208888233
   PubMed Web of Science ®Google Scholar
• ThompsonAJTillotsonSSmithIBrain MRI changes in phenylketonuria. Associations with dietary statusBrain1993116Pt 48118218353710
   PubMed Web of Science ®Google Scholar
• WhiteDAConnorLTNardosBAge-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of the corpus callosumMol Genet Metab201099Suppl 1S41S4620123469
   PubMed Web of Science ®Google Scholar
• GhaziuddinMAl-OwainMAutism spectrum disorders and inborn errors of metabolism: an updatePediatr Neurol201349423223623921282
   PubMed Web of Science ®Google Scholar
• SchiffMBenoistJFAïssaouiSShould metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?PLoS One201167e2193221760924
   PubMed Web of Science ®Google Scholar
• MossJHowlinPAutism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder populationJ Intellect Disabil Res2009531085287319708861
   PubMed Web of Science ®Google Scholar
• CaglayanAOGenetic causes of syndromic and non-syndromic autismDev Med Child Neurol201052213013820059518
   PubMed Web of Science ®Google Scholar
• SaadKElserogyYAbdel RahmanAAADHD, autism and neuroradiological complications among phenylketonuric children in Upper EgyptActa Neurol Belg2015115465766325576444
   PubMed Web of Science ®Google Scholar
• KhemirSHalayemSAzzouzHAutism in Phenylketonuria Patients: From Clinical Presentation to Molecular DefectsJ Child Neurol201631784384926759449
   PubMed Web of Science ®Google Scholar
• EnnsGMKochRBrummVSuboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidenceMol Genet Metab20101012–39910920678948
   PubMed Web of Science ®Google Scholar
• JahjaRHuijbregtsSCde SonnevilleLMvan der MeereJJvan SpronsenFJNeurocognitive evidence for revision of treatment targets and guidelines for phenylketonuriaJ Pediatr20141644e2899
   Web of Science ®Google Scholar
• ChristSEHuijbregtsSCde SonnevilleLMWhiteDAExecutive function in early-treated phenylketonuria: profile and underlying mechanismsMol Genet Metab201099Suppl 1S22S3220123466
   PubMed Web of Science ®Google Scholar
• ArnoldGLVladutiuCJOrlowskiCCBlakelyEMDelucaJPrevalence of stimulant use for attentional dysfunction in children with phenylketonuriaJ Inherit Metab Dis200427213714315159644
   PubMed Web of Science ®Google Scholar
• BurtonBGrantMFeigenbaumAA randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuriaMol Genet Metab2015114341542425533024
   PubMed Web of Science ®Google Scholar
• FeilletFMacdonaldAHartung PerronDBurtonBHartungDOutcomes beyond phenylalanine: an international perspectiveMol Genet Metab201099Suppl 1S79S8520123476
   PubMed Web of Science ®Google Scholar
• SurteesRBlauNThe neurochemistry of phenylketonuriaEur J Pediatr2000159Suppl 2S109S11311043156
   PubMed Web of Science ®Google Scholar
• StahlSMEssential Psychopharmacology: Neuroscientific Basis and Practical Applications2nd edNew York, NYCambridge University Press2000
   Google Scholar
• GuldbergPReyFZschockeJA European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotypeAm J Hum Genet199863171799634518
   PubMed Web of Science ®Google Scholar
• GuldbergPGüttlerFMutations in the phenylalanine hydroxylase gene: methods for their characterizationActa Paediatr199483S4072733
   Web of Science ®Google Scholar
• VockleyJAnderssonHCAntshelKMPhenylalanine hydroxylase deficiency: diagnosis and management guidelineGenet Med201416218820024385074
   PubMed Web of Science ®Google Scholar
• SinghRHRohrFFrazierDRecommendations for the nutrition management of phenylalanine hydroxylase deficiencyGenet Med201416212113124385075
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edWashington, DCAmerican Psychiatric Association2013
   Google Scholar
• RoidGHStanford-Binet Intelligence Scales5th edRolling Meadows, ILRiverside Publishing2003
   Google Scholar
• BainSKAllinJDBook Review: Stanford-Binet Intelligence Scales, Fifth EditionJ Psychoeduc Assess20052318795
   Google Scholar
• Echo Armman Childhood Autism Rating Scale (CARS)Autism World Retrieved2007328
   Google Scholar
• LambertNHartsoughCSandovalJManual for the Children’s Attention and Adjustment SurveyCircle Pines, MNAmerican Guidance Service1990
   Google Scholar
• SadekAAEmamAMAlhaggagyMYClinicolaboratory profile of phenylketonuria (PKU) in Sohag University Hospital-Upper EgyptEgyptian J Med Human Genet2013143293298
   Google Scholar
• KarimzadehPAlaeeMRZarafshanHThe Association between EEG Abnormality and Behavioral Disorder: Developmental Delay in PhenylketonuriaISRN Pediatr2012201297620622550595
   PubMedGoogle Scholar
• Abdel-SalamGMHAbdel-KaderAAInicalLEElectroencephalographic (EEG), neuroradiological and molecular (PKU) patientsEgypt J Neurol Psychiatry Neurosurg2005422390406
   Google Scholar
• WaisbrenSENoelKFahrbachKPhenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysisMol Genet Metab2007921–2637017591452
   PubMed Web of Science ®Google Scholar
• BurgardPDevelopment of intelligence in early treated phenylketonuriaEur J Pediatr2000159Suppl 2S74S7911043149
   PubMed Web of Science ®Google Scholar
• SmithIBeasleyMGAdesAEIntelligence and quality of dietary treatment in phenylketonuriaArch Dis Child19906554724782357082
   PubMed Web of Science ®Google Scholar
• LeuzziVMannarelliDMantiFAge-related psychophysiological vulnerability to phenylalanine in phenylketonuriaFront Pediatr2014225725003100
   PubMed Web of Science ®Google Scholar
• MantiFNardecchiaFPaciSPredictability and inconsistencies in the cognitive outcome of early treated PKU patientsJ Inherit Metab Dis201740679379928836033
   PubMed Web of Science ®Google Scholar
• BaieliSPavoneLMeliCFiumaraAColemanMAutism and phenylketonuriaJ Autism Dev Disord200333220120412757360
   PubMed Web of Science ®Google Scholar
• FombonneEdu MazaubrunCPrevalence of infantile autism in four French regionsSoc Psychiatry Psychiatr Epidemiol19922742032101411750
   PubMed Web of Science ®Google Scholar
• ChenCHHsiaoKJA Chinese classic phenylketonuria manifested as autismBr J Psychiatry19891552512532597924
   PubMed Web of Science ®Google Scholar
• SteinerCEAcostaAXGuerreiroMMMarques-de-FariaAPGenotype and natural history in unrelated individuals with phenylketonuria and autistic behaviorArq Neuropsiquiatr2007652A20220517607414
   PubMed Web of Science ®Google Scholar
• ZafeiriouDIVerveriAVargiamiEChildhood autism and associated comorbiditiesBrain Dev200729525727217084999
   PubMed Web of Science ®Google Scholar
• OkadoNMechanisms for formation and maintenance of synapses mediated by biogenic amines: pathogenesis and therapy of mental retardation and developmental disabilities by genetic and epigenetic factorsKaibogaku Zasshi199974335136210577264
   PubMedGoogle Scholar
• AntshelKMWaisbrenSEDevelopmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expressionJ Abnorm Child Psychol200331656557414658738
   PubMed Web of Science ®Google Scholar
• GonzálezMJGutiérrezAPGassióRNeurological complications and behavioral problems in patients with phenylketonuria in a follow-up unitMol Genet Metab2011104SupplS73S7921821452
   PubMed Web of Science ®Google Scholar
• WyrwichKWAugustePYuREvaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Sub-scale in PhenylketonuriaValue Health201518440441226091594
   PubMed Web of Science ®Google Scholar
• AndersonPJWoodSJFrancisDEAre neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?Dev Neuropsychol200732264566817931123
   PubMed Web of Science ®Google Scholar